Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

VASOPRESSIN SIGNALING PATHWAY VIA RECEPTOR TYPE 2 (PW:0000713)

View Ontology Report

Description

Vasopressin (Avp) acts as an antidiuretic hormone and as a neuromodulator and neurotransmitter. Avp exerts its actions by binding to two receptor types, G-protein coupled receptors coupling to particular G alpha subunits of heterotrimeric G proteins. An important and probably the best characterized role of Avp is in the regulation of water homeostasis by signaling via receptor type 2. Water homeostasis is maintained through the regulation of intravascular blood volume and osmolality; the

Pathway Diagram:

Ariadne Genomics Inc. Aqp2 Gnas Adcy6 Gnas --+> Adcy6 cAMP water Aqp2 ---- Sipa1 Sipa1 Rab11a water reabsorption Akap7 ---- protein kinase A (PKA) signaling pathway Akap7 ---- Pde4d protein kinase A (PKA) signaling pathway --+> Aqp2 protein kinase A (PKA) signaling pathway --+> Aqp2 water ---> water reabsorption protein kinase A (PKA) signaling pathway --+> Pde4d Avpr2 ---- Gnas ATP ATP ---> cAMP cAMP --+> protein kinase A (PKA) signaling pathway Avp ---- Avpr2 Rab11a ---- Rab11fip2 Myo5b ---- Rab11a Myo5b ---- Rab11fip2 Pde4d ---| cAMP Pde4d Akap7 Rab11fip2 Snap23 Vamp2 Myo5b protein kinase A (PKA) signaling pathway G protein mediated signaling pathway via Galphas family Avp Avpr2
GO TO:

Genes in Pathway:


show annotations for term's descendants           Sort by:
vasopressin signaling pathway via receptor type 2 term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Adcy2 adenylate cyclase 2 ISO SMPDB SMP:00322 NCBI chr 1:36,204,054...36,650,645
Ensembl chr 1:36,204,054...36,650,645
JBrowse link
G Adcy3 adenylate cyclase 3 IEA KEGG rno:04962 NCBI chr 6:32,819,602...32,923,174
Ensembl chr 6:32,843,961...32,923,173
JBrowse link
G Adcy6 adenylate cyclase 6 ISO
IDA
IMP
IEA
KEGG
RGD
PMID:18431594 PMID:15579502 PMID:18971210 rno:04962, RGD:2312656, RGD:2313211, RGD:2312654 NCBI chr 7:131,621,860...131,642,923
Ensembl chr 7:131,621,860...131,642,770
JBrowse link
G Adcy9 adenylate cyclase 9 IEA KEGG rno:04962 NCBI chr10:11,645,373...11,768,462
Ensembl chr10:11,645,282...11,765,792
JBrowse link
G Akap7 A-kinase anchoring protein 7 ISO
IDA
RGD PMID:18431594 PMID:15037626 RGD:2312656, RGD:1303982 NCBI chr 1:21,906,503...22,168,663
Ensembl chr 1:21,906,676...22,037,090
JBrowse link
G Aqp2 aquaporin 2 TAS
IDA
IMP
IEA
KEGG
RGD
PMID:18431594 PMID:15579502 PMID:18971210 PMID:15037626 rno:04962, RGD:2312656, RGD:2313211, RGD:2312654, RGD:1303982 NCBI chr 7:132,590,286...132,595,321
Ensembl chr 7:132,590,225...132,595,319
JBrowse link
G Aqp3 aquaporin 3 (Gill blood group) IEA KEGG rno:04962 NCBI chr 5:61,035,165...61,040,683
Ensembl chr 5:61,035,166...61,040,685
JBrowse link
G Aqp4 aquaporin 4 IEA KEGG rno:04962 NCBI chr18:6,782,389...6,799,034
Ensembl chr18:6,782,389...6,799,098
JBrowse link
G Arhgdia Rho GDP dissociation inhibitor alpha IEA KEGG rno:04962 NCBI chr10:106,352,858...106,356,347
Ensembl chr10:106,353,491...106,356,347
JBrowse link
G Arhgdib Rho GDP dissociation inhibitor beta IEA KEGG rno:04962 NCBI chr 4:171,554,139...171,573,057
Ensembl chr 4:171,554,140...171,573,068
JBrowse link
G Avp arginine vasopressin TAS
ISO
IEA
KEGG
RGD
PMID:18431594 PMID:14624682 rno:04962, RGD:2312656, RGD:1579891 NCBI chr 3:138,246,544...138,248,522
Ensembl chr 3:138,246,554...138,248,522
JBrowse link
G Avpr2 arginine vasopressin receptor 2 TAS
ISO
IMP
IEA
KEGG
SMPDB
RGD
PMID:18431594 PMID:14624682 PMID:18971210 SMP:00322 rno:04962, RGD:2312656, RGD:1579891, RGD:2312654 NCBI chr  X:156,785,009...156,787,477
Ensembl chr  X:156,785,139...156,787,477
JBrowse link
G Creb1 cAMP responsive element binding protein 1 IEA KEGG rno:04962 NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:73,397,306...73,466,339
JBrowse link
G Creb3l1 cAMP responsive element binding protein 3-like 1 IEA KEGG rno:04962 NCBI chr 3:98,408,240...98,449,104
Ensembl chr 3:98,408,058...98,449,104
JBrowse link
G Creb3l2 cAMP responsive element binding protein 3-like 2 IEA KEGG rno:04962 NCBI chr 4:66,874,623...66,990,962
Ensembl chr 4:66,387,126...66,990,832
JBrowse link
G Creb3l3 cAMP responsive element binding protein 3-like 3 IEA KEGG rno:04962 NCBI chr 7:9,273,320...9,281,755
Ensembl chr 7:9,273,338...9,281,778
JBrowse link
G Creb3l4 cAMP responsive element binding protein 3-like 4 IEA KEGG rno:04962 NCBI chr 2:177,987,981...177,994,568
Ensembl chr 2:177,987,981...177,993,485
JBrowse link
G Dctn1 dynactin subunit 1 IEA KEGG rno:04962 NCBI chr 4:117,228,722...117,261,528
Ensembl chr 4:117,219,349...117,261,528
JBrowse link
G Dctn2 dynactin subunit 2 IEA KEGG rno:04962 NCBI chr 7:64,977,338...64,992,875
Ensembl chr 7:64,977,363...64,992,873
JBrowse link
G Dctn4 dynactin subunit 4 IEA KEGG rno:04962 NCBI chr18:56,251,187...56,279,844
Ensembl chr18:56,252,780...56,279,842
JBrowse link
G Dctn5 dynactin subunit 5 IEA KEGG rno:04962 NCBI chr 1:176,689,176...176,705,907
Ensembl chr 1:186,119,913...186,137,146
JBrowse link
G Dctn6 dynactin subunit 6 IEA KEGG rno:04962 NCBI chr16:58,077,595...58,096,604
Ensembl chr16:64,780,735...64,801,060
JBrowse link
G Dync1h1 dynein cytoplasmic 1 heavy chain 1 IEA KEGG rno:04962 NCBI chr 6:135,436,375...135,502,117
Ensembl chr 6:135,430,750...135,502,116
JBrowse link
G Dync1i1 dynein cytoplasmic 1 intermediate chain 1 IEA KEGG rno:04962 NCBI chr 4:34,819,313...35,132,647
Ensembl chr 4:34,819,430...35,142,319
JBrowse link
G Dync1i2 dynein cytoplasmic 1 intermediate chain 2 IEA KEGG rno:04962 NCBI chr 3:76,441,621...76,492,782
Ensembl chr 3:76,424,469...76,492,782
JBrowse link
G Dync1li1 dynein cytoplasmic 1 light intermediate chain 1 IEA KEGG rno:04962 NCBI chr 8:123,254,823...123,288,496
Ensembl chr 8:123,254,859...123,289,167
JBrowse link
G Dync1li2 dynein, cytoplasmic 1 light intermediate chain 2 IEA KEGG rno:04962 NCBI chr19:538,207...561,110
Ensembl chr19:538,211...561,107
JBrowse link
G Dync2h1 dynein cytoplasmic 2 heavy chain 1 IEA KEGG rno:04962 NCBI chr 8:12,473,955...12,697,075
Ensembl chr 8:12,473,955...12,697,058
JBrowse link
G Dync2li1 dynein cytoplasmic 2 light intermediate chain 1 IEA KEGG rno:04962 NCBI chr 6:15,745,350...15,778,166
Ensembl chr 6:15,745,350...15,778,166
JBrowse link
G Dynll1 dynein light chain LC8-type 1 IEA KEGG rno:04962 NCBI chr12:46,945,291...46,976,867
Ensembl chr12:46,973,050...46,976,861
JBrowse link
G Dynll2 dynein light chain LC8-type 2 IEA KEGG rno:04962 NCBI chr10:73,264,260...73,283,042
Ensembl chr10:73,264,261...73,272,285
JBrowse link
G Fshr follicle stimulating hormone receptor ISO SMPDB SMP:00322 NCBI chr 6:10,952,329...11,160,288
Ensembl chr 6:10,952,329...11,160,288
JBrowse link
G Gnas GNAS complex locus ISO
IDA
IMP
IEA
KEGG
SMPDB
RGD
PMID:18431594 PMID:14624682 PMID:15579502 PMID:18971210 SMP:00322 rno:04962, RGD:2312656, RGD:1579891, RGD:2313211, RGD:2312654 NCBI chr 3:183,489,648...183,554,570
Ensembl chr 3:183,503,243...183,554,536
JBrowse link
G Gnb1 G protein subunit beta 1 ISO SMPDB SMP:00322 NCBI chr 5:171,357,778...171,424,489
Ensembl chr 5:171,357,797...171,424,488
JBrowse link
G Gng12 G protein subunit gamma 12 ISO SMPDB SMP:00322 NCBI chr 4:97,340,830...97,464,422
Ensembl chr 4:97,340,472...97,464,476
JBrowse link
G Myo5b myosin Vb TAS RGD PMID:18431594 RGD:2312656 NCBI chr18:70,313,717...70,613,918
Ensembl chr18:70,311,990...70,613,918
JBrowse link
G Nsf N-ethylmaleimide sensitive factor, vesicle fusing ATPase IEA KEGG rno:04962 NCBI chr10:89,227,937...89,357,383
Ensembl chr10:89,227,937...89,367,621
JBrowse link
G Pde4d phosphodiesterase 4D ISO RGD PMID:18431594 RGD:2312656 NCBI chr 2:41,748,337...43,262,567
Ensembl chr 2:42,110,838...43,262,569
JBrowse link
G Prkaca protein kinase cAMP-activated catalytic subunit alpha IEA KEGG rno:04962 NCBI chr19:41,059,843...41,083,189
Ensembl chr19:41,059,843...41,086,494
JBrowse link
G Prkacb protein kinase cAMP-activated catalytic subunit beta IEA
ISO
KEGG
SMPDB
SMP:00322 rno:04962 NCBI chr 2:238,297,140...238,389,317
Ensembl chr 2:238,300,127...238,386,315
JBrowse link
G Prkx protein kinase cAMP-dependent X-linked catalytic subunit IEA KEGG rno:04962 NCBI chr  X:45,701,747...45,745,210
Ensembl chr  X:45,701,747...45,745,066
JBrowse link
G Rab11a RAB11a, member RAS oncogene family ISO
IEA
KEGG
RGD
PMID:18431594 rno:04962, RGD:2312656 NCBI chr 8:74,118,922...74,141,760
Ensembl chr 8:74,118,922...74,141,837
JBrowse link
G Rab11b RAB11B, member RAS oncogene family IEA KEGG rno:04962 NCBI chr 7:15,223,613...15,236,754
Ensembl chr 7:15,223,534...15,236,756
JBrowse link
G Rab11fip2 RAB11 family interacting protein 2 ISO RGD PMID:18431594 RGD:2312656 NCBI chr 1:268,908,825...269,080,691
Ensembl chr 1:268,909,413...269,079,661
JBrowse link
G Rab5a RAB5A, member RAS oncogene family IEA KEGG rno:04962 NCBI chr 9:6,720,057...6,749,456
Ensembl chr 9:6,721,122...6,749,447
JBrowse link
G Rab5b RAB5B, member RAS oncogene family IEA KEGG rno:04962 NCBI chr 7:1,693,971...1,712,936
Ensembl chr 7:1,693,989...1,712,780
JBrowse link
G Rab5c RAB5C, member RAS oncogene family IEA KEGG rno:04962 NCBI chr10:86,142,872...86,166,449
Ensembl chr10:86,142,873...86,166,449
JBrowse link
G Sipa1 signal-induced proliferation-associated 1 ISO RGD PMID:18431594 RGD:2312656 NCBI chr 1:212,367,867...212,379,952
Ensembl chr 1:212,367,867...212,377,497
JBrowse link
G Snap23 synaptosome associated protein 23 TAS RGD PMID:18431594 RGD:2312656 NCBI chr 3:127,966,184...127,999,929
Ensembl chr 3:127,967,886...127,998,067
JBrowse link
G Stx4 syntaxin 4 IEA KEGG rno:04962 NCBI chr 1:191,880,549...191,890,333
Ensembl chr 1:191,881,559...191,896,774
JBrowse link
G Vamp2 vesicle-associated membrane protein 2 ISO
IEA
KEGG
RGD
PMID:18431594 rno:04962, RGD:2312656 NCBI chr10:54,292,423...54,296,657
Ensembl chr10:54,292,806...54,296,654
JBrowse link

Pathway Gene Annotations

Disease Annotations Associated with Genes in the vasopressin signaling pathway via receptor type 2
Disease TermsGene Symbols
3p deletion syndromeRab5a
46 XX gonadal dysgenesisFshr
acrodysostosisPde4d
Acrodysostosis 2, with or without Hormone ResistancePde4d
acromegalyGnas
acromesomelic dysplasia, Maroteaux typeAqp3
ACTH-independent macronodular adrenal hyperplasiaGnas
ACTH-independent macronodular adrenal hyperplasia 1Gnas , Prkaca
Acute Coronary SyndromeArhgdib
acute kidney failureAvp
acute lymphoblastic leukemiaGnb1
adrenal cortical adenomaPrkaca , Prkacb
Adrenal Gland NeoplasmsGnas , Prkaca
adrenoleukodystrophyAvpr2
Aicardi-Goutieres Syndrome 3Sipa1
alcohol dependenceAvp , Creb1
alcohol use disorderAvp , Creb1
alcohol withdrawal syndromeAvp
Alpers-Huttenlocher syndromeAqp4
Alzheimer's diseaseAqp4 , Dync1h1 , Gnas
amenorrheaCreb3l3 , Fshr
amnestic disorderAvp , Creb1
amphetamine abuseCreb1 , Myo5b , Pde4d , Prkaca
amyotrophic lateral sclerosisAqp4 , Dctn1 , Dync1h1
amyotrophic lateral sclerosis type 1Dctn1
amyotrophic lateral sclerosis type 8Gnas
Angina PectorisAvp
Angiomatoid Fibrous HistiocytomaCreb1
Animal Disease ModelsAqp4
anxiety disorderAvp , Creb1 , Gnb1
asphyxiating thoracic dystrophyDync2h1 , Dync2li1
asphyxiating thoracic dystrophy 1Dync2h1 , Dync2li1
asphyxiating thoracic dystrophy 3Dync1h1 , Dync2h1
asthmaAdcy2 , Pde4d
ataxia telangiectasiaDync2h1
atrophic muscular diseaseDync1h1
autism spectrum disorderAqp4 , Creb1 , Dync1h1 , Gnb1 , Nsf
autistic disorderAqp4 , Avp , Avpr2 , Prkx , Rab11b
Autoinflammatory Disease, Familial, Behcet-Like-3Sipa1
autosomal dominant cerebellar ataxiaDync1h1
autosomal dominant distal hereditary motor neuronopathyDync1h1
autosomal dominant distal hereditary motor neuronopathy 14Dctn1 , Dync1h1
autosomal dominant dyskeratosis congenita 6Dync1li2
autosomal dominant intellectual developmental disorderGnb1
autosomal dominant intellectual developmental disorder 13Dync1h1
autosomal dominant intellectual developmental disorder 42Gnb1
autosomal dominant intellectual developmental disorder 6Arhgdib
autosomal hemophilia AAvpr2
autosomal recessive intellectual developmental disorder 41Rab5c
Autosomal Recessive Nonsyndromic Deafness 123Stx4
autosomal recessive polycystic kidney diseaseDync2h1
B-Cell Chronic Lymphocytic LeukemiaGnas
Bardet-Biedl syndromeSipa1
Barth syndromeAvpr2
Beemer-Langer syndromeDync2h1
biliary tract benign neoplasmPrkacb
Binge DrinkingAqp4
bipolar disorderAdcy2
blindnessAqp4
Bloom syndromeRab11a , Snap23
brachydactylyGnas
brain edemaAqp3 , Aqp4
Brain InjuriesAqp4 , Pde4d
brain ischemiaAqp3 , Aqp4 , Creb1 , Dynll1 , Prkaca , Prkacb
branched-chain keto acid dehydrogenase kinase deficiencyStx4
Breast Cancer, FamilialDctn5
Breast NeoplasmsArhgdia , Dync2h1
Cafe-au-Lait SpotsGnas
cardiac arrestDynll1
Cardiac ArrhythmiasAvp
Cardioacrofacial Dysplasia 1Prkaca
Cardioacrofacial Dysplasia 2Prkacb
cardiomyopathyAdcy3 , Aqp2 , Avp , Avpr2
cataract 15 multiple typesDctn2
cataract 5 multiple typesDync1li2
central pontine myelinolysisAqp4
cerebellar ataxiaDync1h1
cerebellar hypoplasiaDync1h1
cerebral amyloid angiopathyAqp4
cerebral creatine deficiency syndrome 1Avpr2
Cerebral HemorrhageAqp4
cerebral malariaAqp4
cerebral palsyGnb1
Charcot-Marie-Tooth diseaseDctn1 , Dctn2 , Dync1h1
Charcot-Marie-Tooth disease axonal type 2ODync1h1
Charcot-Marie-Tooth disease axonal type 2UDctn2
Charcot-Marie-Tooth disease type 1Dync1h1
Charcot-Marie-Tooth disease type 2Dctn1 , Dync1h1
Charcot-Marie-Tooth disease type 4Dync1h1
Charcot-Marie-Tooth disease type 5Dync1h1
Chemical and Drug Induced Liver InjuryAvp
childhood spinal muscular atrophyDync1h1
ChloracneRab11a
cholangiocarcinomaGnas , Prkaca , Prkacb
Chromosome 16q12 Duplication SyndromeDync1li2
chromosome 18q deletion syndromeAqp4
chromosome 1p36 deletion syndromeGnb1
Chromosome Xq28 Duplication SyndromeAvpr2
chronic kidney diseaseArhgdia
chronic myeloid leukemiaSipa1
ciliopathyDync2h1
cleft palateGnb1
cocaine abuseCreb1
cocaine dependenceAvp , Creb1
Cocaine-Related DisordersAvp , Creb1
colorectal cancerRab11a , Snap23
common variable immunodeficiencyVamp2
complex cortical dysplasia with other brain malformationsDync1h1
complex cortical dysplasia with other brain malformations 13Dync1h1
congenital adrenal hyperplasiaAvpr2
congenital disorder of glycosylation type IIbDctn1
congenital disorder of glycosylation type IIcCreb3l1
congenital heart diseaseDync2h1
congenital myasthenic syndrome 8Gnb1
congestive heart failureAvp , Avpr2 , Creb1 , Dynll1 , Gnb1 , Prkaca
COVID-19Dynll1
Crohn's diseaseMyo5b
Cushing SyndromeGnas , Prkacb
cystic fibrosisDctn4
DeafnessAqp4
DehydrationAvp
depressive disorderCreb1 , Gnb1 , Pde4d
developmental and epileptic encephalopathy 96Nsf
Developmental DisabilitiesCreb3l1 , Dync1h1 , Gnb1
diabetes insipidusAqp2 , Avp
diabetes mellitusAdcy3 , Aqp4
diabetic angiopathyAdcy3
diabetic ketoacidosisAqp2
Diabetic NephropathiesAqp2 , Creb1
diabetic retinopathyAqp4
Diamond-Blackfan anemiaVamp2
diarrheaMyo5b
Diffuse Axonal InjuryAqp4
dilated cardiomyopathyCreb1 , Stx4
dilated cardiomyopathy 1LLGnb1
distal arthrogryposis type 1AAqp3
drug dependenceCreb1
Drug OverdoseAvp
Duane retraction syndromeGnas
dyschromatosis symmetrica hereditariaCreb3l4
dyskeratosis congenitaAvpr2 , Vamp2
DysmenorrheaAvp
dystoniaDctn1 , Gnb1
Ehlers-Danlos syndrome spondylodysplastic type 2Gnb1
Emery-Dreifuss muscular dystrophyAvpr2
endocrine system diseaseGnas
epilepsyAdcy9 , Dync1h1 , Gnb1
epilepsy with generalized tonic-clonic seizuresGnb1
esophageal atresiaPde4d , Sipa1
Esophageal NeoplasmsAqp3
Experimental Autoimmune EncephalomyelitisAqp4
Experimental Diabetes MellitusAqp2 , Aqp4 , Avp
Experimental Liver CirrhosisArhgdib , Creb1 , Snap23
ExsanguinationAvp
factor VIII deficiencyAvpr2
Failure to ThriveGnb1
familial adenomatous polyposis 1Dctn4
familial melanomaDctn2
favismAvpr2
Febrile SeizuresAvp
fetal akinesia deformation sequence syndrome 1Dync1h1
fetal alcohol spectrum disorderAvp
Fetal Growth RetardationDync2h1
fibrolamellar carcinomaPrkaca
focal epilepsyGnb1
frontotemporal dementiaDctn1
frontotemporal dementia and/or amyotrophic lateral sclerosis 6Aqp3
fundus dystrophyDync2h1
galactosemiaAqp3
GallstonesGnas
GAND syndromeCreb3l4
Gastrointestinal HemorrhageAvp
gastrointestinal stromal tumorCreb3l4
generalized epilepsy with febrile seizures plus 9Stx4
genetic diseaseAdcy3 , Adcy6 , Aqp2 , Arhgdia , Avp , Avpr2 , Creb3l1 , Dctn1 , Dync1h1 , Dync2h1 , Dync2li1 , Fshr , Gnas , Gnb1 , Myo5b , Pde4d , Prkacb , Rab11b , Rab5c , Vamp2
glycogen storage disease VSipa1
Goldberg-Shprintzen syndromeGnb1
gonadal dysgenesisFshr
granulosa cell tumorFshr
Growth DisordersAvpr2 , Gnb1
growth hormone secreting pituitary adenomaGnas
hemorrhagic diseaseDync2li1 , Gnas
hepatocellular carcinomaGnas
hereditary breast ovarian cancer syndromeDynll2 , Fshr , Nsf
Hereditary Neoplastic SyndromesDctn4
hereditary spastic paraplegia 4Gnas
heroin dependenceCreb1
Herpes Simplex EncephalitisAqp4
Heterotopic OssificationGnas
Hirschsprung's diseaseDync2h1
holoprosencephalyCreb1
holoprosencephaly 2Dync2li1
human immunodeficiency virus infectious diseaseArhgdia , Arhgdib , Rab11b
Huntington's diseaseCreb1
Huntington's disease-like 1Avp
hydrocephalusAqp4
hydronephrosisAqp2
HyperalgesiaAqp4 , Avp
hyperglycemiaAvp
hypertensionAqp2 , Aqp4 , Arhgdia , Avp , Avpr2 , Creb1 , Dynll1 , Gnas
HYPERTRIGLYCERIDEMIA 1Creb3l3
HYPERTRIGLYCERIDEMIA 2Creb3l3
HypoalgesiaAqp4
Hypoglossal Nerve InjuriesPrkaca , Prkacb
hypoglycemiaCreb1
HyponatremiaAvp
HypotensionAvp
hypothyroidismAqp3 , Gnb1
HypoventilationDctn1
HypoxiaGnas
Idiopathic Generalized EpilepsyAdcy9 , Gnb1
immunodeficiency 132ADync1h1
immunodeficiency 16Gnb1
immunodeficiency 33Avpr2
immunodeficiency 38Gnb1
immunodeficiency 42Creb3l4
immunodeficiency 90Sipa1
impotenceDynll1
inappropriate ADH syndromeAvp
infantile Refsum diseaseCreb3l1
inflammatory bowel disease 1Myo5b
inherited metabolic disorderMyo5b
Inosine Triphosphatase DeficiencyAvp
Insulin ResistanceGnas
intellectual disabilityAqp4 , Creb3l1 , Dync1h1 , Dync2h1 , Dynll2 , Gnas , Gnb1 , Gng12 , Myo5b , Rab11a , Sipa1
INTERSTITIAL LUNG AND LIVER DISEASEDctn2
intestinal diseaseMyo5b
ischemiaAvp
Joubert syndrome 1Dynll2
Joubert syndrome 25Gnb1
Kabuki syndromeAdcy6
KeloidArhgdia
Kohlschutter-Tonz syndromeAdcy9
Language Development DisordersGnb1
Lethal Congenital Contracture Syndrome 8Adcy6
Li-Fraumeni syndromeVamp2
lissencephalyDync1h1
Liver NeoplasmsMyo5b
lung adenocarcinomaAqp4
lung small cell carcinomaAvp
Lymphatic MetastasisAqp3
Lynch syndromeDync2li1
major depressive disorderAdcy3
malariaAqp4
McCune Albright syndromeGnas
Megalencephalic Leukoencephalopathy with Subcortical Cysts 4Aqp4
melanomaSipa1
Memory DisordersAvp , Creb1
Meniere's diseaseAqp4
Metabolic Bone DiseasesGnas
metabolic dysfunction-associated steatotic liver diseaseCreb1 , Prkaca
Methylmalonyl-CoA Epimerase DeficiencyDctn1
MHC class II deficiencyCreb3l4
microcephalyDync1h1 , Gnb1 , Rab11a
MicrognathismDync2h1
microvillus inclusion diseaseMyo5b
middle cerebral artery infarctionAqp4 , Creb1 , Dynll1
mixed fibrolamellar hepatocellular carcinomaPrkaca
mood disorderAdcy9 , Dctn1
morbid obesityAdcy3
morphine dependenceCreb1
morphine withdrawal syndromeAvp , Creb1
motor peripheral neuropathyDync1h1
mucolipidosis type IVRab11b
Muscle HypotoniaGnb1
Muscle WeaknessDync1h1
myelodysplastic syndromeGnb1
myocardial infarctionCreb1
Myocardial IschemiaRab5a , Snap23
myopathyDync1h1
nemaline myopathy 6Rab11a
Neoplasm MetastasisArhgdia , Creb1
Neoplasm Recurrence, LocalCreb3l4
nephrogenic diabetes insipidusAqp2 , Aqp3 , Avpr2
nephrogenic diabetes insipidus type 2Aqp2
nephrogenic syndrome of inappropriate antidiuresisAvpr2
nephrotic syndromeArhgdia
nephrotic syndrome type 1Arhgdia
nephrotic syndrome type 8Arhgdia
Nervous System MalformationsDync1h1
neuroblastomaGnas
neurodegenerative diseaseDctn1
Neurodevelopmental Disorder with Ataxic Gait, Absent Speech, and Decreased Cortical White MatterRab11b
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND AUTISTIC FEATURES WITH OR WITHOUT HYPERKINETIC MOVEMENTSVamp2
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIESDync1i2
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ARTHROGRYPOSIS, AND STRUCTURAL BRAIN ANOMALIESDync1h1
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIESDync1i2
Neurodevelopmental DisordersAdcy9 , Creb1 , Dync1h1 , Gnb1 , Pde4d , Prkaca , Prkx , Rab11b , Vamp2
neurohypophyseal diabetes insipidusAvp
neuromyelitis opticaAqp4
neuronal ceroid lipofuscinosisRab11a
neuropathyDctn1 , Dync1h1
newborn respiratory distress syndromeDync2h1
nicotine dependenceCreb1
obesityAdcy3 , Gnas
obsessive-compulsive disorderCreb1
ocular hypertensionAqp4
OliguriaAvpr2
opiate dependenceAvp
opiate withdrawal syndromeAvp
opioid abuseAvp , Creb1
optic atrophyDync2h1
Optic Nerve InjuriesAqp4
optic neuritisAqp4
Opticospinal Multiple SclerosisAqp4
Orthostatic HypotensionGnas
osteochondrodysplasiaDync2h1
osteogenesis imperfecta type 16Creb3l1
ovarian dysgenesis 1Fshr
ovarian hyperstimulation syndromeFshr
Ovarian NeoplasmsAqp3 , Fshr
PainAvp
pancreatic cancerGnas
pantothenate kinase-associated neurodegenerationAvp
papillary thyroid carcinomaDync1h1
paraplegiaAqp3 , Avpr2 , Dctn2
Parasitic Liver DiseasesGnas
parathyroid carcinomaCreb3l4
Parkinson's diseaseCreb1
ParkinsonismAqp4 , Dctn1
pathologic nystagmusGnb1
peripheral nervous system diseaseDctn1 , Dync1h1 , Dync1i1
periventricular nodular heterotopiaAvpr2
Peroxisome Biogenesis Disorder, Complementation Group 7Gnb1
Perrault Syndrome 1Fshr
Perry syndromeDctn1
Pick's diseaseCreb1
Pitt-Hopkins-like syndrome 2Fshr
pituitary adenoma 3Gnas
Pituitary NeoplasmsGnas
pleomorphic xanthoastrocytomaCreb3l2 , Dync1i1
Pneumococcal MeningitisAqp4
polycystic kidney diseaseGnas
polycystic ovary syndromeFshr , Gnas
polyneuropathyDync1h1
PolyuriaAqp2 , Avp
portal hypertensionAvp
Postoperative Cognitive DysfunctionCreb1
Precocious PubertyGnas
Prenatal Exposure Delayed EffectsCreb1
PresbycusisAqp4
primary biliary cholangitisAqp4
primary ciliary dyskinesiaAqp3
primary hyperaldosteronismGnas
primary microcephalyRab11a
primary ovarian insufficiency 16Fshr
primary pigmented nodular adrenocortical disease 4Prkaca
primary pulmonary hypertensionCreb1
Progressive Familial Intrahepatic Cholestasis 10Myo5b
progressive osseous heteroplasiaGnas
prostate adenocarcinomaCreb3l4
prostate carcinoma in situCreb3l4
Prostatic NeoplasmsCreb3l4 , Pde4d , Prkacb , Stx4
pseudohypoaldosteronismGnas
pseudohypoparathyroidismGnas
pseudohypoparathyroidism type 1AGnas
pseudohypoparathyroidism type 1BGnas
pseudohypoparathyroidism type 1CGnas
Pseudomonas InfectionsDctn4
pseudopseudohypoparathyroidismGnas
psychotic disorderAvp
Pulmonary Arterial HypertensionCreb1
Pulmonary Surfactant Metabolism Dysfunction 1Rab5b
RASopathyCreb3l3
Reperfusion InjuryAqp4
Respiration DisordersGnas
retinal diseaseAqp4
retinal vein occlusionAqp4
retinitis pigmentosaDync2h1
rhizomelic chondrodysplasia punctata type 5Dync1h1
Rubinstein-Taybi syndromeAdcy9
schizophreniaAvp , Creb1 , Gnas
sciatic neuropathyCreb1
sensorineural hearing lossStx4
Sepsis-Associated EncephalopathyAqp4
severe congenital encephalopathy due to MECP2 mutationAvpr2
severe congenital neutropenia 3Creb3l4
severe congenital neutropenia 5Creb3l4
sex cord-gonadal stromal tumorGnas
ShockAvp
short chain acyl-CoA dehydrogenase deficiencyDynll1
Short-Rib Thoracic Dysplasia 15 with PolydactylyDync2li1
short-rib thoracic dysplasia 6 with or without polydactylyDync2h1 , Dync2li1
short-rib thoracic dysplasia 9 with or without polydactylyAdcy9
Shprintzen-Goldberg CraniosynostosisGnb1
Shy-Drager SyndromeAvp
sitosterolemiaDync2li1
sitosterolemia 1Dync2li1
sitosterolemia 2Dync2li1
skin melanomaCreb1
Skin NeoplasmsAqp3
Spinal Cord InjuriesAdcy3 , Aqp4 , Pde4d
Spinal Cord Reperfusion InjuryCreb1
spinal muscular atrophyDctn1 , Dync1h1
spinal muscular atrophy with lower extremity predominantDync1h1
spinal muscular atrophy with lower extremity predominant 1Dync1h1
Spinocerebellar AtaxiasDync1h1
SplenomegalyAvpr2
split hand-foot malformation 5Dync1i2
squamous cell carcinomaAqp3
status epilepticusAqp4
steatotic liver diseaseCreb1
strabismusGnb1
StrokeAvp , Pde4d
Subarachnoid HemorrhageAqp4
substance dependenceCreb1
substance-related disorderAkap7
syndromic X-linked intellectual disability Lubs typeAvpr2
synucleinopathyDctn1 , Dctn2
TachycardiaGnas
Talipes CavusDync1h1
Tatton-Brown-Rahman syndromeAdcy3
temporal lobe epilepsyAqp4 , Avp , Nsf
teratomaCreb3l1
thrombocytopeniaDync2li1
thymomaAqp4
Tongue NeoplasmsAqp3
transient cerebral ischemiaAqp4 , Creb1 , Pde4d
transverse myelitisAqp4
type 1 diabetes mellitusAvp
type 2 diabetes mellitusAvp
ureteral obstructionAdcy6 , Avpr2
urinary bladder cancerAqp3
uveitisAqp4
VACTERL associationDync2h1
vascular dementiaAvp , Creb1
Ventricular Dysfunction, RightCreb1
very long chain acyl-CoA dehydrogenase deficiencyVamp2
Walker-Warburg syndromeAqp4
Weight GainDync1li2
Wernicke-Korsakoff syndromeAvp
withdrawal disorderAvp , Creb1 , Gnas
X-linked monogenic diseaseAvpr2
X-linked nephrogenic diabetes insipidusAqp2 , Avpr2
Zellweger syndromeCreb3l1
Pathway Annotations Associated with Genes in the vasopressin signaling pathway via receptor type 2
Pathway TermsGene Symbols
acebutolol pharmacodynamics pathwayPrkaca
adenine phoshoribosyltransferase deficiency pathwayPde4d
adenosine monophosphate deaminase deficiency pathwayPde4d
adenosine signaling pathwayAdcy2 , Creb1 , Gnas , Gnb1 , Gng12 , Prkacb
adenylosuccinate lyase deficiency pathwayPde4d
adrenergic beta receptor agonist and beta-blocker pharmacodynamics pathwayPrkaca
AICA-ribosuria pathwayPde4d
amiloride pharmacodynamics pathwayAqp2 , Aqp3
amiodarone pharmacodynamics pathwayPrkaca
amlodipine pharmacodynamics pathwayPrkaca
amyotrophic lateral sclerosis pathwayRab5a
antigen processing and presentation pathwayCreb1
apoptotic cell death pathwayPrkaca , Prkacb , Prkx
atenolol pharmacodynamics pathwayPrkaca
autophagy pathwayRab11a , Rab5a
azathioprine pharmacodynamics pathwayPde4d
bendroflumethiazide pharmacodynamics pathwayAqp2 , Aqp3
betaxolol pharmacodynamics pathwayPrkaca
bile acid transport pathwayAdcy2 , Adcy3 , Adcy6 , Adcy9 , Aqp4 , Gnas , Prkaca , Prkacb , Prkx
bisoprolol pharmacodynamics pathwayPrkaca
bumetanide pharmacodynamics pathwayAqp2 , Aqp3
bupranolol drug pathwayPrkaca
bupranolol pharmacodynamics pathwayPrkaca
calcium/calcium-mediated signaling pathwayAdcy2 , Adcy3 , Adcy9 , Gnas , Prkaca , Prkacb , Prkx
carvedilol pharmacodynamics pathwayPrkaca
Chagas disease pathwayGnas
chemokine mediated signaling pathwayAdcy2 , Adcy3 , Adcy6 , Adcy9 , Gnb1 , Gng12 , Prkaca , Prkacb , Prkx
chlorothiazide pharmacodynamics pathwayAqp2 , Aqp3
chlorthalidone pharmacodynamics pathwayAqp2 , Aqp3
cilostazol pharmacodynamics pathwayPde4d
corticotropin-releasing hormone signaling pathwayGnas
cystinuria pathwayAqp2 , Aqp3
dilated cardiomyopathy pathwayAdcy2 , Adcy3 , Adcy6 , Adcy9 , Gnas , Prkaca , Prkacb , Prkx
diltiazem pharmacodynamics pathwayPrkaca
dipyridamole pharmacodyamics pathwayPde4d
disopyramide pharmacodynamics pathwayPrkaca
dobutamine pharmacodynamics pathwayPrkaca
dopamine signaling pathwayPrkaca , Prkacb
dopamine signaling pathway via D1 family of receptorsAdcy2 , Gnas , Gnb1 , Gng12 , Prkacb
E-cadherin signaling pathwayAqp3 , Stx4
eicosanoid signaling pathwayGnb1 , Prkaca , Rab11a
endocytosis pathwayRab11a , Rab11b , Rab11fip2 , Rab5a , Rab5b , Rab5c
endoplasmic reticulum stress - the unfolded protein response pathwayCreb3l1 , Creb3l2 , Creb3l3 , Creb3l4
endothelin signaling pathwayAdcy2 , Adcy3 , Adcy6 , Adcy9
Entamoebiasis pathwayGnas , Prkaca , Prkacb , Prkx , Rab5a , Rab5b , Rab5c
epinephrine signaling pathway via adrenergic receptor betaGnas
eplerenone pharmacodynamics pathwayAqp2 , Aqp3
esmolol pharmacodynamics pathwayPrkaca
etacrynic acid pharmacodynamics pathwayAqp2 , Aqp3
flecainde pharmacodynamics pathwayPrkaca
follicle-stimulating hormone signaling pathwayAdcy2 , Creb1 , Fshr , Gnas , Gnb1 , Gng12 , Prkacb
forkhead class A signaling pathwayCreb1
fosphenytoin pharmacodynamics pathwayPrkaca
furosemide pharmacodynamics pathwayAqp2 , Aqp3
G protein mediated signaling pathway via Galpha12/Galpha13 familyGnb1
G protein mediated signaling pathway via Galphas familyAdcy2 , Adcy3 , Adcy6 , Adcy9 , Avpr2 , Gnas
glucagon signaling pathwayAdcy6 , Gnas
glutamate signaling pathwayAdcy2 , Adcy3 , Adcy6 , Adcy9 , Gnas , Gnb1 , Gng12 , Prkaca , Prkacb , Prkx
gonadotropin-releasing hormone signaling pathwayAdcy2 , Adcy3 , Adcy6 , Adcy9 , Gnas , Prkaca , Prkacb , Prkx
granulocyte-macrophage colony-stimulating factor signaling pathwayPrkaca , Prkacb
Hartnup disease pathwayAqp2 , Aqp3
Hedgehog signaling pathwayGnb1 , Prkaca , Prkacb , Prkx
histamine signaling pathway, immunologicalAdcy2 , Creb1 , Gnas , Gnb1 , Gng12 , Prkacb
Huntington's disease pathwayCreb1 , Creb3l1 , Creb3l2 , Creb3l3 , Creb3l4 , Dctn1 , Dctn2 , Dctn4
hydrochlorothiazide pharmacodynamics pathwayAqp2 , Aqp3
hydroflumethiazide pharmacodynamics pathwayAqp2 , Aqp3
hypoxia inducible factor pathwayCreb1
ibutilide pharmacodynamics pathwayPrkaca
iminoglycinuria pathwayAqp2 , Aqp3
insulin responsive facilitative sugar transporter mediated glucose transport pathwayMyo5b , Rab11a , Rab5a , Snap23 , Stx4 , Vamp2
insulin secretion pathwayVamp2
insulin signaling pathwayPrkaca , Prkacb , Prkx
interleukin-3 signaling pathwayPrkaca , Prkacb
isoprenaline pharmacodynamics pathwayPrkaca
isradipine pharmacodynamics pathwayPrkaca
Kelley-Seegmiller syndrome pathwayPde4d
Lesch-Nyhan syndrome pathwayPde4d
levobunolol pharmacodynamics pathwayPrkaca
lidocaine pharmacodynamics pathwayPrkaca
long term depressionGnas
long term potentiationPrkaca , Prkacb , Prkx
luteinizing hormone signaling pathwayAdcy2 , Creb1 , Gnas , Gnb1 , Gng12 , Prkacb
lysinuric protein intolerance pathwayAqp2 , Aqp3
melanocortin system pathwayAdcy2 , Gnas , Gnb1 , Gng12 , Prkacb
mercaptopurine pharmacodynamics pathwayPde4d
metolazone pharmacodynamics pathwayAqp2 , Aqp3
metoprolol pharmacodynamics pathwayPrkaca
mexiletine pharmacodynamics pathwayPrkaca
mitochondria transport pathwayDctn1 , Dctn2 , Dctn4 , Dctn5 , Dctn6 , Dync1h1 , Dync1i1 , Dync1i2 , Dync1li1 , Dync1li2 , Dynll1 , Dynll2
mitogen activated protein kinase signaling pathwayGng12 , Prkaca , Prkacb , Prkx
molybdenum cofactor deficiency pathwayPde4d
N-cadherin signaling pathwayDctn1
nadolol pharmacodynamics pathwayPrkaca
nebivolol pharmacodynamics pathwayPrkaca
neurotrophic factor signaling pathwayArhgdia , Arhgdib
nifedipine pharmacodynamics pathwayPrkaca
nimodipine pharmacodynamics pathwayPrkaca
nisoldipine pharmacodynamics pathwayPrkaca
nitrendipine pharmacodynamics pathwayPrkaca
Notch signaling pathwayRab11a
penbutolol pharmacodynamics pathwayPrkaca
phagocytosis pathwayDync1h1 , Dync1i1 , Dync1i2 , Dync1li1 , Dync1li2 , Dync2h1 , Rab5a , Rab5b , Rab5c
phenytoin pharmacodynamics pathwayPrkaca
phosphatidylinositol 3-kinase-Akt signaling pathwayPrkaca
pindolol pharmacodynamics pathwayPrkaca
platelet-derived growth factor signaling pathwayArhgdia , Rab5a , Sipa1
prion disease pathwayPrkaca , Prkacb , Prkx
procainamide pharmacodynamics pathwayPrkaca
propranolol pharmacodynamics pathwayPrkaca
prostaglandin D2 signaling pathwayAdcy2 , Gnas , Gnb1 , Gng12 , Prkacb
prostaglandin I2 signaling pathwayAdcy2 , Gnas , Gnb1 , Gng12 , Prkacb
prostate cancer pathwayCreb1 , Creb3l1 , Creb3l2 , Creb3l3 , Creb3l4
protein kinase A (PKA) signaling pathwayAdcy2 , Adcy3 , Adcy6 , Adcy9 , Akap7 , Pde4d , Prkaca , Prkacb
purine metabolic pathwayAdcy2 , Adcy3 , Adcy6 , Adcy9 , Pde4d
purine nucleoside phosphorylase deficiency pathwayPde4d
quinidine pharmacodynamics pathwayPrkaca
Rab family mediated signaling pathwayRab11a , Rab5a
serotonin signaling pathway via receptors engaging G alphas protein familyAdcy2 , Creb1 , Gnas , Gnb1 , Gng12 , Prkacb
sotalol pharmacodynamics pathwayPrkaca
spironolactone pharmacodynamics pathwayAqp2 , Aqp3
syndecan signaling pathwayPrkaca
timolol pharmacodynamics pathwayPrkaca
tioguanine pharmacodynamics pathwayPde4d
torasemide pharmacodynamics pathwayAqp2 , Aqp3
transforming growth factor-beta Smad dependent signaling pathwayCreb1
triamterene pharmacodynamics pathwayAqp2 , Aqp3
trichlormethiazide pharmacodynamics pathwayAqp2 , Aqp3
tuberculosis pathwayCreb1 , Rab5a , Rab5b , Rab5c
vascular endothelial growth factor signaling pathwayPrkaca
vasopressin signaling pathwayAdcy6 , Akap7 , Aqp2 , Avp , Avpr2 , Gnas , Myo5b , Pde4d , Rab11a , Rab11fip2 , Sipa1 , Snap23 , Vamp2
vasopressin signaling pathway via receptor type 1Avp
vasopressin signaling pathway via receptor type 2Adcy2 , Adcy3 , Adcy6 , Adcy9 , Akap7 , Aqp2 , Aqp3 , Aqp4 , Arhgdia , Arhgdib , Avp , Avpr2 , Creb1 , Creb3l1 , Creb3l2 , Creb3l3 , Creb3l4 , Dctn1 , Dctn2 , Dctn4 , Dctn5 , Dctn6 , Dync1h1 , Dync1i1 , Dync1i2 , Dync1li1 , Dync1li2 , Dync2h1 , Dync2li1 , Dynll1 , Dynll2 , Fshr , Gnas , Gnb1 , Gng12 , Myo5b , Nsf , Pde4d , Prkaca , Prkacb , Prkx , Rab11a , Rab11b , Rab11fip2 , Rab5a , Rab5b , Rab5c , Sipa1 , Snap23 , Stx4 , Vamp2
verapamil pharmacodynamics pathwayPrkaca
visual phototransduction pathwayGnb1
water transport pathwayAqp2 , Aqp3 , Aqp4
Wnt signaling pathwayPrkaca , Prkacb , Prkx
xanthinuria type I pathwayPde4d
xanthinuria pathwayPde4d
xanthinuria type II pathwayPde4d
Phenotype Annotations Associated with Genes in the vasopressin signaling pathway via receptor type 2

References Associated with the vasopressin signaling pathway via receptor type 2:

Ontology Path Diagram:

paths to the root
paths to the root

Import into Pathway Studio: